SmithKline consumer health sales jump 21% not including Sterling contribution.
This article was originally published in The Tan Sheet
Executive Summary
SMITHKLINE CONSUMER HEALTHCARE SALES JUMP 21% IN THIRD QUARTER, not including the contribution from Sterling Winthrop's non-U.S. business acquired last year. Including the contribution from the Sterling acquisition, SmithKline Beecham's overall consumer healthcare sales rose 51% in the quarter to [pound]538 mil., or $855 mil. (based on the currency translation of [pound]=$1.59 and assuming comparable exchange rates). The consumer segment's operating profit increased 73% to [pound]104, or $165 mil., in the quarter